PUBLISHER: iData Research Inc. | PRODUCT CODE: 1676624
PUBLISHER: iData Research Inc. | PRODUCT CODE: 1676624
The global bone graft substitute (BGS) market was valued at approximately $2.83 billion in 2024 and is expected to grow at a CAGR of 4.1%, reaching approximately $3.75 billion by 2031. The market includes various types of bone graft substitutes used in orthopedic, trauma, and reconstructive surgeries.
The BGS market is segmented into:
The market is further categorized based on indication type:
Market Insights
Market Trends
Market Share Insights
Top Competitors in the Global Bone Graft Substitute Market (2024):
1 Medtronic
* Market leader due to a dominant share in the DBM and synthetic BGS segments.
* Grafton(R) - The first fiber-based DBM allograft BGS and one of the most widely used.
* MASTERGRAFT(R) - Synthetic BGS product line available in granules, moldable putty, flexible strip, and matrix EXT.
2 Stryker
* Second-largest competitor in the market.
* Offers multiple BGS products including Vitoss(TM), ALLOMATRIX(R), FUSIONFLEX(R), and PRO-STIM(R).
3 DePuy Synthes (Johnson & Johnson)
* Third-largest competitor in the BGS market.
* Competes with its DBX(R) DBM product line and chronOS(R) synthetic BGS.
Global Research Scope
* North America: United States, Canada
* Latin America: Brazil, Mexico, Chile, Colombia
* Western Europe: Germany, France, Italy, Spain, United Kingdom
* Central & Eastern Europe: Poland, Russia, Turkey
* Middle East: Saudi Arabia, UAE, Israel
* Asia Pacific: China, Japan, India, South Korea
* Africa: South Africa, Egypt, Nigeria
Quantitative Coverage
Qualitative Coverage
Data Sources